EGFR and non-small cell lung carcinoma: Corroborating to this finding, analysis of an NSCLC scRNA‐seq dataset (GSE131907)[27] revealed that the NT5E expression was predominantly contributed by malignant epithelial cells, with particularly higher levels in EGFR‐mutant tumors than the WT (Figure 4b).